The Leader in
RNA Innovation

Committed to driving the field of oncology diagnostics forward

Explore our Tests
Record Breaking TAT
Receive your NGS results in 10 days or less
Click Here
Liquid Trace™
Introducing the first comprehensive cfDNA and cfRNA test for clinical use. >300 cfDNA genes >1600 cfRNA genes Pan-Tumor Assay for Both Solid Tumors and Hematologic Malignancies
Click Here

Genomic Testing:
Answers in 10 days or less

Keep your business running smoothly and let Computera tech specialists assist you by providing the best solutions for your business. Schedule an onsite appointment at your office and we can discuss your needs.

Don’t accept partial results.

Advancing Precision in Cancer Diagnostics
Cancer is a complex disease requiring comprehensive answers. Only a comprehensive answer will allow medical professionals to make the highest quality care decisions for their patients.  

GTC Provides Comprehensive Answers

At Genomic Testing Cooperative we analyze both DNA and RNA which gives the best possible answers based on our current knowledge. Our tests detect all biomarkers.

Comprehensive NGS testing & cell-free DNA/RNA Profiling

Our genomic testing is focused on comprehensive profiling of DNA and RNA in hematologic neoplasms and solid tumors, embracing the latest sequencing technology and informatics tools, thereby providing better insights into the patient’s tumor signature.

Next-generation sequencing of DNA, RNA and cell-free (cfDNA cfRNA) Profiling

Our genomic testing is focused on comprehensive profiling of DNA and RNA in hematologic neoplasms and solid tumors, embracing the latest sequencing technology and informatics tools, thereby providing better insights into the patient’s tumor signature.

  • GTC’s RNA sequencing capabilities go beyond just the detection of fusions and include alternative splicing, gene expression and prediction.
  • Our RNA profiling can be used to complement flow cytometry and immunohistochemistry (IHC) testing. GTC’s capabilities include liquid biopsy testing that give physicians testing options when tissue or bone marrow isn’t available.
View All Tests

Next-generation sequencing of DNA, RNA and cell-free (cfDNA cfRNA) Profiling

Both solid tumors (lung, colon, breast, etc) and hematologic malignancies (leukemia, multiple myeloma, etc) have molecular profiling tests available.

All major types of cancer have molecular testing that can be performed on them but the sample requirements will be different.

GTC’s informatics tools use artificial intelligence with sophisticated algorithms to interpret complex data sets; these informatics tools are unmatched anywhere on the market today.

View All Tests

GTC consistently delivers results
in 10 days or less

Comprehensive Hematologic Molecular Profiling enables the detection and differentiation of driver and sub-clonal mutations, determines prognosis and identifies targeted therapies for personalized medicine.

Genomic Testing Cooperative also offers comprehensive next generation sequencing of DNA and RNA for solid tumors including cancers of the lung, pancreas, brain, colon, breast, ovary, endometrium, thyroid, head and neck and soft tissue (sarcoma and GIST).

Exeptional Turnaround Time

What Makes GTC Different

Fast and Efficient

Lorem ipsum dolor sit amet, consectet adipiscing elit, sed do por incididunt ut labore et dolore

Experienced Professionals

Lorem ipsum dolor sit amet, consectet adipiscing elit, sed do por incididunt ut labore et dolore

Advanced Solutions

Lorem ipsum dolor sit amet, consectet adipiscing elit, sed do por incididunt ut labore et dolore

Competitive Prices

Lorem ipsum dolor sit amet, consectet adipiscing elit, sed do por incididunt ut labore et dolore

Friendly & Reliable

Lorem ipsum dolor sit amet, consectet adipiscing elit, sed do por incididunt ut labore et dolore

Convenient queues

Lorem ipsum dolor sit amet, consectet adipiscing elit, sed do por incididunt ut labore et dolore

What Our Co-Op Members Say

"Joining the Genomic Testing Cooperative strengthened our operational rigor. The member community enables practical benchmarking of assay validation, quality-control workflows, and documentation practices, helping us maintain consistent analytical performance while shortening the time required to adopt well-vetted best practices"
John Mitchell, Co-Founder, Libera Labs
John Mitchell, Co-Founder, Libera Labs
“The GTC provides a structured environment for aligning on evidence standards and interpretive consistency. Access to peer expertise supports more disciplined decision-making around test selection, reporting conventions, and clinically actionable findings—reducing variability across teams and improving confidence in downstream clinical use.”
Donna Torres, Bioinformatics Lead,
Donna Torres, Bioinformatics Lead,
“As a GTC member, we’ve benefited from disciplined peer exchange on bioinformatics pipelines and variant interpretation governance. The cooperative’s focus on reproducibility—version control, validation criteria, and audit-ready documentation—has helped us reduce analytical variability and strengthen confidence in longitudinal comparisons.”
Ellice Waters, CTO, Brandbotics
Ellice Waters, CTO, Brandbotics
Extremely Low QNS & TNP Rate

Less than 0.5% of our tests result in a QNS (2023-2025 results)

  • Our assays cover all clinically relevant genes including tumor mutation burden (TMB), MSI, HRD, fusion/translocations, copy number variation, amplification, and deletions.
  • Our reports provide full interpretation and presentation of clinical relevance for diagnosis, therapy, prognosis, heterogeneity and potential clinical trials.
Having Computer issues?

Cooperatively we can all work together to improve community access to comprehensive genomic profiling and advance scientific discovery

Genomic Testing Cooperative works with laboratories, hospitals, pathologists, oncologists, and other medical professionals to improve access to cutting edge technology in genomic testing at an affordable price by sharing resources and expertise.

Gain access to advanced technology, molecular expertise, and a pipeline for innovation and development of new tests.

Genomic Testing Cooperative utilizes technology innovations that integrate artificial intelligence and proprietary algorithms within our informatics tools.  These tools enable faster turnaround times of results, comprehensive reporting including targeted and immunotherapy recommendations and clinical trial options.

Learn About The Co-Op Model